Call to expand pharmacy blood pressure service as study finds heightened stroke risk among black people Researchers found that stroke incidence was twice as high in Black African and Black Caribbean populations compared with white populations, with rates consistently higher in socioeconomically deprived areas.…
Apixaban linked to lower risk of recurrent blood clots compared with warfarin Compared with warfarin, people in both frail and non-frail cohorts taking apixaban experienced an average of 12.1 fewer days of home time loss, a study found.…
Investigational anti-clotting drug reduced stroke risk by more than one-quarter, study finds Researchers observed a 17% reduction in major cardiovascular events in patients who took asundexian compared with the placebo group.…
News round-up: long COVID, chikungunya and free supplies of ciprofloxacin Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Weight-loss drug to be offered to patients at risk of stroke or heart attack In response to the new recommendation, sector leaders have called for the NHS to “mobilise the pharmacy network” as weight-loss medications are offered to an increasing number of patients.…
Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
Community pharmacy cholesterol testing pilot expands across east London Under the scheme, pharmacies use a seven-minute test to assess patients’ cholesterol levels and offer an estimate of their risk of heart problems over the next ten years.…
Management of hypertrophic cardiomyopathy Pharmacological treatment approaches for hypertrophic cardiomyopathy, including pharmacogenomic considerations for first-in-class myosin inhibitors.…
Embedding pharmacist-led lipid optimisation clinics in cardiac rehabilitation Cardiology pharmacist Niharika Duggal shares how her integrated care system launched a pilot project in Coventry and Warwickshire to tackle the gap in cardiovascular disease care.…
Managing patients with cardiorenal metabolic disease An overview of the pathophysiology of cardiorenal metabolic disease, medication optimisation strategies and the role of the pharmacist in medication management and patient education.…
